Last 106.30 INR
Change Today -1.70 / -1.57%
Volume 137.2K
SVLS On Other Exchanges
Symbol
Exchange
Natl India
As of 2:43 AM 07/28/14 All times are local (Market data is delayed by at least 15 minutes).

suven life sciences ltd (SVLS) Snapshot

Open
108.70
Previous Close
108.00
Day High
108.70
Day Low
105.40
52 Week High
07/8/14 - 116.19
52 Week Low
07/31/13 - 22.11
Market Cap
12.5B
Average Volume 10 Days
745.1K
EPS TTM
0.72
Shares Outstanding
116.8M
EX-Date
07/24/14
P/E TM
147.5x
Dividend
0.50
Dividend Yield
2.34%
Current Stock Chart for SUVEN LIFE SCIENCES LTD (SVLS)

Related News

No related news articles were found.

suven life sciences ltd (SVLS) Related Businessweek News

No Related Businessweek News Found

suven life sciences ltd (SVLS) Details

Suven Life Sciences Limited, a research-based biopharmaceutical company, designs, manufactures, and supplies bulk actives, drug intermediates, and fine chemicals for the life science industry worldwide. It provides advanced intermediates, intermediates, and active pharmaceutical ingredients. The company also offers contract research and manufacturing services, including development and supply of pharmaceutical and agro chemical intermediates for new chemical entities. In addition, it provides discovery and development of new chemical entities for CNS disorders; research collaborative projects with pharmaceutical companies; and drug discovery research services, including in-vitro screening and molecular biology, drug metabolism and pharmacokinetics, pharmacology, toxicology and genotoxicity, and bioanalysis, as well as operates a formulation development center. The company was formerly known as Suven Pharmaceuticals Pvt. Ltd. and changed its name to Suven Life Sciences Limited in 2003. Suven Life Sciences Limited was founded in 1989 and is based in Hyderabad, India.

Founded in 1989

suven life sciences ltd (SVLS) Top Compensated Officers

Chairman, Chief Executive Officer, Chairman o...
Total Annual Compensation: 12.0M
Wholetime Director, Member of Investor Grieva...
Total Annual Compensation: 5.4M
Compensation as of Fiscal Year 2014.

suven life sciences ltd (SVLS) Key Developments

Suven Life Sciences Limited - Shareholder/Analyst Call

Suven Life Sciences Limited - Shareholder/Analyst Call

Suven Life Sciences Limited Reports Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2014

Suven Life Sciences Limited reported audited standalone earnings results for the fourth quarter and full year ended March 31, 2014. For the quarter, net sales/income from operations was INR 1,308.034 against INR 747.036 a year ago. Profit from operations before other income finance costs and exceptional items were INR 451.618 against INR 114.479 a year ago. Profit from ordinary activities before tax was INR 446.696 against INR 92.834 a year ago. Net profit for the period was INR 324.056 or INR 2.77 per basic and diluted share before extraordinary items against INR 86.304 or INR 0.74 per basic and diluted share before extraordinary items year ago. For the full year, net sales/income from operations was INR 5,103.124 against INR 2,578.846 a year ago. Profit from operations before other income finance costs and exceptional items were INR 2,102.212 against INR 453.184 a year ago. Profit from ordinary activities before tax was INR 2,027.379 against INR 328.524 a year ago. Net profit for the period was INR 1,441.575 or INR 12.34 per basic and diluted share before extraordinary items against INR 308.395 or INR 2.64 per basic and diluted share before extraordinary items year ago.

Suven Life Sciences Limited Recommends Dividend on Common Share and Special Dividend for the Financial Year 2013-14, Payable on and from August 26, 2014

Suven Life Sciences Limited has announced that the board of directors of the company at its meeting held on May 22, 2014, has proposed a dividend of INR 0.50 per share (50% of face value INR 1.00 each), with an additional special silver jubilee year dividend of INR 2.00 per share (200% of face value of INR 1.00 each), aggregating to INR 2.50 per share for the financial year 2013-14, the dividend will be paid on and from August 26, 2014 to the members as on book closure date, subject to the approval of members in the upcoming annual general meeting.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SVLS:IN 106.25 INR -1.75

SVLS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SVLS.
View Industry Companies
 

Industry Analysis

SVLS

Industry Average

Valuation SVLS Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUVEN LIFE SCIENCES LTD, please visit www.suven.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.